pfizer glp 1 agonist Sciwind Biosciences partners with China to commercialise Biased GLP-1 in China in $495 M deal Pfizer selects new drug for
Description
Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.
Stay on Track
Ideal Partner Profiles
Mercedez Hernandez walks through what patients should consider when weighing their options.
Experts say more education and awareness are needed.
The G in GLP-1 might as well stand for gold.
